The San Diego Business Journal summarizes local biotech giants Illumina and Life Technologies’ race to the $1000 genome. Spoiler alert – analysts favor Illumina’s Solexa technology over Life Tech’s SOLiD.
http://www.sdbj.com/article.asp?aID=144667&link=perm
Advertisement